首页> 外文期刊>Molecular BioSystems >Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS
【24h】

Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS

机译:使用凝集素微阵列和nanoLC-MS / MS对结肠癌患者组织进行糖组学分析

获取原文
获取原文并翻译 | 示例
           

摘要

The current study evaluated the glycoproteomic profile of tissues from colon cancer patients. The lectin microarray was first performed to compare the glycoprotein profiles between colon cancer and matched normal tissues. Level of N-acetylglucosamine (GlcNAc) that Solarium tuberosum lectin (STL) bound was found to be elevated in colon cancer, which was verified through lectin histochemistry. The subsequent glycoproteomic analysis based on STL enrichment of glycoproteins followed by label-free quantitative nano liquid chromatography-mass spectrometry/mass spectrometry (nanoLC-MS/MS) analysis identified 72 proteins in high confidence. Among these proteins, 17 were exclusively detected in cancer tissues, and 14 were significantly upregulated in tumor tissues. Annexin A1 and HSP90β were chosen for further investigation by immunoprecipitation coupled with lectin blots, western blots and tissue microarrays. Both Annexin A1 and HSP90P were GlcNAcylated, and their protein expressions were elevated in colon cancer, compared to normal tissues. Moreover, specific changes of GlcNAc abundances in Annexin A1 and HSP90β suggested that tumor-specific glycan patterns could serve as candidate biomarkers of colon cancer for distinguishing cancer patients from healthy individuals.
机译:当前的研究评估了结肠癌患者组织的糖蛋白组学特征。首先进行凝集素微阵列比较结肠癌和匹配的正常组织之间的糖蛋白谱。发现在结肠癌中日光浴马铃薯凝集素(STL)结合的N-乙酰氨基葡萄糖(GlcNAc)水平升高,这已通过凝集素组织化学证实。随后基于糖蛋白STL富集的糖蛋白组学分析,然后进行无标记的定量纳米液相色谱-质谱/质谱(nanoLC-MS / MS)分析,高信度鉴定出72种蛋白质。在这些蛋白质中,仅在癌组织中检测到17种蛋白质,而在肿瘤组织中显着上调了14种蛋白质。选择膜联蛋白A1和HSP90β进行免疫沉淀,结合凝集素印迹,蛋白质印迹和组织微阵列进行进一步研究。与正常组织相比,膜联蛋白A1和HSP90P都被GlcNAcy酰化,并且它们的蛋白表达在结肠癌中升高。此外,膜联蛋白A1和HSP90β中GlcNAc丰度的特定变化表明,肿瘤特异性聚糖模式可作为结肠癌的候选生物标志物,以区分癌症患者与健康个体。

著录项

  • 来源
    《Molecular BioSystems》 |2013年第7期|1877-1887|共11页
  • 作者单位

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China;

    Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China;

    High-throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biotechnology and Medicine, Tianjin 300457, China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, Beijing 100853, China;

    Department of Pathology, Yanbian University College of Medicine, No. 977, Park-Road, MailBox # 375, Yanji-city 133002, China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    Department of Gastroenterology, Affiliated Hospital of Beihua University, Jilin 132001, China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China,High-throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biotechnology and Medicine, Tianjin 300457, China,College of Life Sciences and Tianjin State Laboratory of Protein Science, Nankai University, Tianjin 300071, China;

    Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China;

    State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, P.R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号